BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15377901)

  • 41. A comparison of the success rates of endoscopic-assisted probing in the treatment of membranous congenital nasolacrimal duct obstruction between younger and older children and its correlation with the thickness of the membrane at the Valve of Hasner.
    Gupta N; Neeraj C; Smriti B; Sima D
    Orbit; 2018 Aug; 37(4):257-261. PubMed ID: 29040026
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endonasal balloon dacryoplasty in partial and complete obstruction of dacryocystorhinostomy ostium.
    At'kova EL; Krakhovetskiy NN; Zhukov OV
    Vestn Oftalmol; 2021; 137(1):13-20. PubMed ID: 33610144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Balloon catheter dilation and nasolacrimal duct intubation for treatment of nasolacrimal duct obstruction after failed probing.
    Repka MX; Chandler DL; Holmes JM; Hoover DL; Morse CL; Schloff S; Silbert DI; Tien DR;
    Arch Ophthalmol; 2009 May; 127(5):633-9. PubMed ID: 19433712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Probing in Congenital Nasolacrimal Duct Obstruction in Children Older Than 2 Years.
    Une VL; Kulkarni SS; Nandedkar VS
    J Pediatr Ophthalmol Strabismus; 2019 May; 56(3):141-145. PubMed ID: 31116859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary Monocanalicular Stent Intubation for Children With Congenital Nasolacrimal Duct Obstruction: Surgical Outcome and Risk Factors.
    Katowitz WR; Prat DL; Munroe CE; Revere K; Khatib L; Hua P; Ying GS; Binenbaum G
    Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):490-495. PubMed ID: 35502807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Balloon catheter dilation for treatment of persistent nasolacrimal duct obstruction.
    Lueder GT
    Am J Ophthalmol; 2002 Mar; 133(3):337-40. PubMed ID: 11860970
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Congenital nasolacrimal duct obstruction: irrigation or probing?
    Kim YS; Moon SC; Yoo KW
    Korean J Ophthalmol; 2000 Dec; 14(2):90-6. PubMed ID: 11213741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in children.
    Dolmetsch AM; Gallon MA; Holds JB
    Ophthalmic Plast Reconstr Surg; 2008; 24(5):390-3. PubMed ID: 18806661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monocanalicular versus bicanalicular silicone intubation for congenital nasolacrimal duct obstruction.
    Andalib D; Gharabaghi D; Nabai R; Abbaszadeh M
    J AAPOS; 2010 Oct; 14(5):421-4. PubMed ID: 21035069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors Predictive of Success in Probing for Congenital Nasolacrimal Duct Obstruction.
    Beato J; Mota Á; Gonçalves N; Santos-Silva R; Magalhães A; Breda J; Falcão-Reis F
    J Pediatr Ophthalmol Strabismus; 2017 Mar; 54(2):123-127. PubMed ID: 27977034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparing of Treatment Results of Monocanalicular and Bicanalicular Intubation in Inborn Lacrimal Duct Obstruction].
    Červenka S; Matoušek P; Komínek P
    Cesk Slov Oftalmol; 2016; 72(5):178-181. PubMed ID: 28224803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Success rates of primary probing for congenital nasolacrimal obstruction in children.
    Arora S; Koushan K; Harvey JT
    J AAPOS; 2012 Apr; 16(2):173-6. PubMed ID: 22525175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors affecting the success of nasolacrimal duct probing for congenital nasolacrimal duct obstruction.
    Mannor GE; Rose GE; Frimpong-Ansah K; Ezra E
    Am J Ophthalmol; 1999 May; 127(5):616-7. PubMed ID: 10334364
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bicanalicular double silicone stenting in endoscopic dacryocystorhinostomy with lacrimal trephination in distal or common canalicular obstruction.
    Paik JS; Cho WK; Yang SW
    Eur Arch Otorhinolaryngol; 2012 Jun; 269(6):1605-11. PubMed ID: 22130914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of Lacrijet monocanalicular intubation for congenital nasolacrimal duct obstruction.
    Hamed Azzam S; Hartstein M; Dolmetsch A; Mukari A
    Eur J Ophthalmol; 2022 Nov; 32(6):3340-3345. PubMed ID: 35102761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Effectiveness of Monocanalicular Silicone Intubation for Congenital Nasolacrimal Duct Obstruction Under Nasal Endoscopic Visualization of the Terminal End of the Obstructed Nasolacrimal Duct.
    Han JY; Lee H; Chang M; Park M; Lee JS; Baek S
    J Craniofac Surg; 2015 Jun; 26(4):1328-31. PubMed ID: 26080187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.
    Steindler P; Mantovani E; Incorvaia C; Parmeggiani F
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):837-46. PubMed ID: 19107503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Treatment of Congenital Nasolacrimal Duct Obstruction in Children: A Retrospective Review.
    Eustis HS; Nguyen AH
    J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):65-67. PubMed ID: 28991351
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intralacrimal migration of Masterka
    Fayet B; Racy E; Katowitz WR; Katowitz JA; Ruban JM; Brémond-Gignac D
    J Fr Ophtalmol; 2018 Mar; 41(3):206-211. PubMed ID: 29576330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dilation probing as primary treatment for congenital nasolacrimal duct obstruction.
    Clark RA
    J AAPOS; 2002 Dec; 6(6):364-7. PubMed ID: 12506277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.